An Economic Case for Waiving Intellectual Property Rights on Covid Vaccines

Gopal Roy

India Quarterly: A Journal of International Affairs, 2022, vol. 78, issue 1, 143-147

Abstract: India and South Africa approached the World Trade Organisation to negotiate the temporary waiver of Intellectual Property (IP) rights on Covid-19 vaccines to remove the artificial barrier of patents and boost vaccine production. This commentary advocates for the waiver of IP rights on Covid-19 vaccines. First, the article makes a case for the debate on the validity of the Covid-19 vaccine to qualify for a patent. Market failure and underinvestment in research and development arguments do not hold for granting a patent to Covid vaccines. Next, the article briefly reviews the evidence on the association between vaccination and virus mutations. Evidence suggests that waiving patents is vital to increase vaccination worldwide and curb mutation and reduce the risk of more infectious new variants. Finally, the article argues that the rationale for a patent is economical, based on incentivising innovation and therefore, the losses suffered by various sectors of the economy due to new variant induced fatalities and lockdowns need to be considered for a case for its waiver.

Keywords: Covid-19; vaccination; intellectual property rights; patents; world trade organisation; monopoly (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/09749284221078463 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:indqtr:v:78:y:2022:i:1:p:143-147

DOI: 10.1177/09749284221078463

Access Statistics for this article

More articles in India Quarterly: A Journal of International Affairs
Bibliographic data for series maintained by SAGE Publications ().